Full text
| |
| Author(s): |
Giovanna Barbarini Longato
Total Authors: 1
|
| Document type: | Master's Dissertation |
| Press: | Campinas, SP. |
| Institution: | Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia |
| Defense date: | 2010-02-23 |
| Examining board members: |
João Ernesto de Carvalho;
Frederico Argollo Vanderlinde;
Luciana Konecny Kobe
|
| Advisor: | Mary Ann Foglio; João Ernesto de Carvalho |
| Abstract | |
Cancer is a pool of many diseases diagnosed in thousands of people all over the world and represents the second major cause of death worldwide. The loss of normal cell growth control is the main event in the development of cancer and includes specific steps known as cell proliferation, differentiation and apoptosis. Despite numerous studies related to Piper genus, there is no description of any antiproliferative (in vitro) or antitumoral activity (in vivo) of Piper regnellii (Miq.) C. DC. var. regnellii. The present study evaluated the antiproliferative activity of this species, collected in three different periods: June and October, 2008 and February 2009. Among the plants evaluated, the medium polarity fractions obtained from the dichloromethanic crude extract of the plants collected in June presented concentration-effect correlation and also selectivity towards hormonedependent ovary (OVCAR-3) and breast (MCF7) cell lines, as well as melanoma (UACC- 62) and prostate (PC-3). According to our studies, one of the compounds responsible for this activity is classified as eupomatenoid-5, that is a neolignan. Effects observed in vitro for the lignans enriched fractions were confirmed through the Ehrlich solid tumor model in mice. In addition, preliminary results with dichloromethane crude extract of P. regnellii in anti-inflammatory experimental model of paw edema induced by carrageenan suggest the connection between cancer and inflammation. The present study represents the first report of both antiproliferative and anti-inflammatory promising activities of this species indicating the benefits of further studies in the search of more purified compounds and active principles that in synergism with eupomatenoid-5 can potentiate anticancer activity's result, as well as their mechanisms of action. (AU) | |
| FAPESP's process: | 08/50836-0 - Atividade anticancer de extratos brutos e fracoes ativas obtidos de piper regnellii. |
| Grantee: | Giovanna Barbarini Longato |
| Support Opportunities: | Scholarships in Brazil - Master |